Understanding the Implications
of the Affordable Care Act

Now iPad Compatible


medical loss ratioWith the Affordable Care Act nearly fully implemented, the biopharm industry must adapt to some of the shifts taking place in the marketplace, including:

  • More people with affordable coverage options
  • More treatment options possibly being covered
  • More patients qualifying for Medicaid
  • New pay-for-performance incentives within hospitals and health systems

It’s important for commercial teams to take a hard look at how this changing landscape affects the healthcare industry, the US public, and the business of biopharm.

After completing this course, participants will be able to:

  • Describe the overall concepts of health insurance exchanges, the individual mandate, and the employer mandate—and how they are addressed in the new legislation
  • Discuss the new regulations imposed on health insurance companies
  • Understand what “Essential Health Benefits” are and how they relate to biopharm
  • Describe how Medicaid will be expanded, along with Medicare reforms being put into place
  • Define the goal of comparative effectiveness research
  • Explain the impact of the legislation on various groups, including the uninsured, the insurance industry, hospitals, physicians, and the biopharmaceutical industry

View a brief e-course demonstration

Our e-courses are only available for group and corporate-wide licenses. Pricing is based on the estimated number of users. Please contact us to learn more about incorporating Managed Markets Excellence® into your corporate training program. We can also develop custom training solutions to meet your specific training needs.

 

  • Increased pricing and access pressures
  • Stricter, more centralized provider markets
  • The need for new customer engagement strategies

 

  • Increased pricing and access pressures
  • Stricter, more centralized provider markets
  • The need for new customer engagement strategies